Concepedia

Wen-Son Hsieh

WH

Statistics

Publications

5

Citations

362

H-Index

5

Active since

2006

Affiliations

National University Hospital(Current)

Wen-Son Hsieh is an author at National University Hospital specializing in radiation oncology, health sciences, and cancer therapeutics.

Top concepts

Publications per year

2006–2018

5

Publications

5

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

Alexa B. Schrock, Viola W. Zhu, Wen-Son Hsieh et al. · Journal of Thoracic Oncology · 2018 · 133 citations · Full text

A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma

Ho Yeong Lim, Jeong Heo, Hye Jin Choi et al. · Clinical Cancer Research · 2014 · 99 citations · Full text

Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer

Wen-Son Hsieh, Ross A. Soo, B.K. Peh et al. · Clinical Cancer Research · 2009 · 82 citations

Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma

Andrea Wong, Ross A. Soo, Jiade J. Lu et al. · Annals of Oncology · 2006 · 28 citations · Full text

, , +6

Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma.

Sing Huang Tan, Hiroshi Ida, Boon Cher Goh et al. · PubMed · 2007 · 20 citations

1–5 of 5